03789nam a2200469 a 4500 vtls000051048 KUKTEM 20251117141416.0 m f d cr mnu---uuuuu 110110t2009 dcua fob 000 0 eng d 9780309130394 0309130395 9780309130400 (electronic bk.) 0309130409 (electronic bk.) 9786612239243 6612239247 201107131657 VLOAD 201105101022 jamie 201105100959 ida 201105091524 jamie 201101101221 ida import 2.mrk 605 UMP QD181.U7 M43 2009 Medical isotope production without highly enriched uranium [electronic resource] / Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies Washington, D.C. : National Academies Press, c2009 1 electronic text (xviii, 202 p.) : digital, GIF, PDF, ill. Title from electronic title page (viewed June 1, 2009) Includes bibliographical references Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility Text in GIF and PDF format "This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply" Mode of access : Internet Molybdenum Supply & distribution United States Molybedenum Isolation & purification United States Radioisotopes supply & distribution United States Technetium Compounds isolation & purification United States Uranium Isotopes Uranium Isotopes Therapeutic use Molybdenum Isotopes Therapeutic use Technetium Isotopes Therapeutic use National Research Council (U.S.). Committee on Medical Isotope Production Without Highlty Enriched Uranium NetLibrary http://www.netlibrary.com.libraryumpsa.idm.oclc.org/urlapi.asp?action=summary&v=1&bookid=285289 0 0 0 1 10000 10000 2019-09-04 0 QD181.U7 M43 2009 0000056486 2019-09-04 00:00:00 1 2019-09-04 EBOOK 634293014559499162 16348 16354 VIRTUA40 VTLSSORT0060*0070*0080*0200*0201*0202*0203*0204*0205*0400*0900*2450*2600*3000*5000*5040*5050*5160*5200*5380*6500*6501*6502*6503*6504*6505*6506*6507*7100*8560*9992